Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2008 2
2009 2
2011 1
2012 2
2015 2
2016 1
2017 1
2018 2
2019 2
2020 2
2021 2
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
A cohort study of CNS tumors in Multiple Endocrine Neoplasia Type 1.
Graillon T, Romanet P, Camilla C, Gelin C, Appay R, Roche C, Lagarde A, Mougel G, Farah K, Le Bras M, Engelhardt J, Kalamarides M, Peyre M, Amelot A, Emery E, Magro E, Cebula H, Aboukais R, Bauters C, Jouanneau E, Berhouma M, Cuny T, Dufour H, Loiseau H, Figarella-Branger D, Bauchet L, Binquet C, Barlier A, Goudet P. Graillon T, et al. Among authors: roche c. Clin Cancer Res. 2024 Apr 17. doi: 10.1158/1078-0432.CCR-23-3308. Online ahead of print. Clin Cancer Res. 2024. PMID: 38630553
Somatotroph Tumors and the Epigenetic Status of the GNAS Locus.
Romanet P, Galluso J, Kamenicky P, Hage M, Theodoropoulou M, Roche C, Graillon T, Etchevers HC, De Murat D, Mougel G, Figarella-Branger D, Dufour H, Cuny T, Assié G, Barlier A. Romanet P, et al. Among authors: roche c. Int J Mol Sci. 2021 Jul 15;22(14):7570. doi: 10.3390/ijms22147570. Int J Mol Sci. 2021. PMID: 34299200 Free PMC article.
Brief CommunicationCirculating tumor DNA is present in the most aggressive meningiomas.
Graillon T, Roche C, Basset N, Mougel G, Meyer M, Farah K, Boissonneau S, Fuentes S, Tabouret E, Campello C, Appay R, Figarella-Branger D, Chinot O, Dufour H, Romanet P, Barlier A. Graillon T, et al. Among authors: roche c. Neurooncol Adv. 2020 Jun 7;2(1):vdaa068. doi: 10.1093/noajnl/vdaa068. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 32642718 Free PMC article. No abstract available.
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial.
Graillon T, Sanson M, Campello C, Idbaih A, Peyre M, Peyrière H, Basset N, Autran D, Roche C, Kalamarides M, Roche PH, Fuentes S, Tabouret E, Barrie M, Cohen A, Honoré S, Boucekine M, Baumstarck K, Figarella-Branger D, Barlier A, Dufour H, Chinot OL. Graillon T, et al. Among authors: roche c. Clin Cancer Res. 2020 Feb 1;26(3):552-557. doi: 10.1158/1078-0432.CCR-19-2109. Epub 2020 Jan 22. Clin Cancer Res. 2020. PMID: 31969329 Clinical Trial.
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
Mohamed A, Romano D, Saveanu A, Roche C, Albertelli M, Barbieri F, Brue T, Niccoli P, Delpero JR, Garcia S, Ferone D, Florio T, Moutardier V, Poizat F, Barlier A, Gerard C. Mohamed A, et al. Among authors: roche c. Oncotarget. 2017 Jun 20;8(25):41044-41063. doi: 10.18632/oncotarget.17008. Oncotarget. 2017. PMID: 28454119 Free PMC article.
21 results